Cass Sunstein. Cass Robert Sunstein[1] (born September 21, 1954) is an American legal scholar, particularly in the fields of constitutional law, administrative law, environmental law, and law and behavioral economics, who was the Administrator of the White House Office of Information and Regulatory Affairs in the Obama administration.[2] For 27 years, Sunstein taught at the University of Chicago Law School.[3] Sunstein is currently the Robert Walmsley University Professor[4] and Felix Frankfurter Professor of Law at Harvard Law School. Early life and education[edit] Career[edit] Sunstein worked in the Office of Legal Counsel in the Justice Department as an attorney-advisor (1980–1981) and then took a job as an assistant professor of law at the University of Chicago Law School (1981–1983), where he also became an assistant professor in the Department of Political Science (1983–1985).
In 1985, Sunstein was made a full professor of both political science and law; in 1988, he was named the Karl N. Cass Sunstein: The Regulatory Czar from Hell | Race 4 2012. A rapidly increasing number of Americans from all walks of life are beginning to harbor deep-seated fears about Obama “Regulatory Czar” nominee Cass Sunstein. They fear he would use his radical position on animal rights to devastate the agricultural industry – and the elderly community as well. Those fears are both widespread — and justified. For instance, in a paper entitled “The Rights of Animals: A Very Short Primer,” Sunstein observes that, “that there should be extensive regulation of the use of animals in entertainment, in scientific experiments, and in agriculture.” The paper also asserts that “there is a strong argument, in principle, for bans on many current uses of animals.”
In the same paper, Sunstein suggests that the government should endorse the actions of persons attempting to act on behalf of animals, “to bring private suits to ensure that anti-cruelty and related laws are actually enforced. Not that Mr. And that, in short, means that if the U.S. But, not to worry. Newly-Confirmed Obama Regulatory Czar Cass Sunstein Pro-Abortion, Pro-Cloning. By Steven Ertelt | WASHINGTON, DC | LIFENEWS.COM | 9/15/09 9:00 AM Newly-Confirmed Obama Regulatory Czar Cass Sunstein Pro-Abortion, Pro-Cloning by Steven Ertelt LifeNews.com Editor September 15, 2009 Washington, DC (LifeNews.com) – The Senate recently approved Cass Sunstein as President Obama’s new regulatory czar and, like other members of the administration, more information is coming out about his anti-life views after the fact.
Sunstein was confirmed by the Senate last week as administrator of the White House Office of Information and Regulatory Affairs. Now, reports indicate Sunstein holds pro-abortion and pro-human cloning views that are upsetting for the majority of Americans who are pro-life. In a 2003 review of the book "Our Posthuman Future" by Francis Fukuyama, Sunstein confirmed he has little regard for developing human life in the womb. He said there need not be any regard for unborn children in their earliest days because human embryos are "only a handful of cells. " SunsteinOIRA901.pdf (application/pdf Object) Nudge (book) Nudge: Improving Decisions about Health, Wealth, and Happiness is a book written by University of Chicago economist Richard H. Thaler and Harvard Law School Professor Cass R.
Sunstein. Because of these differences and conflicts between these systems, people are often subject to making mistakes that are the result of widely occurring biases, heuristics, and fallacies. These include: Soft paternalism (also called libertarian paternalism) is the union of two political notions that are commonly viewed as being at odds: libertarianism and paternalism. Thaler and Sunstein point out that many Americans are not saving enough for retirement. Elizabeth Kolbert writing for The New Yorker held reservations about some of the book's conclusions when she wrote that In July 2011, a subgroup of the UK House of Lords Science and Technology Committee concluded a year-long review of behavioral change based on 148 written submissions and evidence from 70 witnesses. Behavioural Insights Team. Cost-benefit analysis. Cost-benefit analysis and the value of a human life « Molivam42's Weblog. It is the French engineer and economist, Jules Dupuit, who is usually credited with the development of cost-benefit analysis.
It began in the evaluation of public works projects but it has since been used to analyse polices in criminal justice, defence, public health and the environment. It can be said to have its origins in Jeremy Bentham and his theory of utilitarianism. The English philosopher argued that the aim of policies should be to provide the greatest happiness for the greatest number. When governments use of cost-benefit analysis to decide whether to build a new road or offer a new drug through the public health system they are often putting a value on the environment or human life, which can be extremely controversial, especially in the latter case.
“Economics is the study of the use of scarce resources which have alternative uses.” Of course a human life has a very different value in the third world. Jim Hacker: Humphrey, we are talking about 100,000 deaths a year. Lives, Years, And Willingness to Pay by Cass R. Sunstein. Value of life. The potency of life (or cost of life) is an economic value assigned to life in general, or to specific living organisms.
[citation needed] In social and political sciences, it is the marginal cost of death prevention in a certain class of circumstances. [citation needed] As such, it is a statistical term, the cost of reducing the average number of deaths by one. It is an important issue in a wide range of disciplines including economics, health care, adoption, political economy, insurance, worker safety, environmental impact assessment, and globalization. [citation needed] In industrial nations, the justice system considers a human life "priceless", thus illegalizing any form of slavery; i.e., humans cannot be bought for any price.
Treatment in economics[edit] There is no standard concept for the value of a specific human life in economics. Policy applications of the VSL[edit] Tobacco industry[edit] Uses[edit] Estimates of the value of life[edit] Life Value in the US[edit] Criticisms[edit] DP-07-05.pdf (application/pdf Object) Putting a Price on Human Life: The Costs and Benefits of Cost-Benefit Analysis. February 25, 2004 John Podesta: Welcome, I'm John Podesta, President of the Center for American Progress. We appreciate your all being here, quite a turnout for a very important book. This is the latest of our breakfast forums and we're here to discuss Lisa and Frank's book about putting a price on human life, the Costs and Benefits of Cost Benefit Analysis. I'm going to turn this panel over.
We're going to get Frank up here I think and I'm going to turn the panel over to Sally Katzen in just a moment, but by way of introduction I'd just like to say that many of us that are on this panel and have been working on this issue for many years. I guess I first met Jim Tousey in the 1970s, and want to thank him for being here today. We probably go back to the day when Ralph Nader was still trying to make cars safer rather than taking a second run for President. I think by any measure of rough justice I think we can see that regulation does work in this country and around the world. (Clapping) Cost-benefit analysis: put a dollar value on human life? Putting a Price Tag on Life: Today, companies and governments often use Jeremy Bentham’s utilitarian logic under the name of “cost-benefit analysis.”
In Michael Sandel's lecture at Harvard, he presents some contemporary cases in which cost-benefit analysis was used to put a dollar value on human life. The cases give rise to several objections to the utilitarian logic of seeking “the greatest good for the greatest number.” Should we always give more weight to the happiness of a majority, even if the majority is cruel or ignoble?
Is it possible to sum up and compare all values using a common measure like money? Ford Pinto Case One of the examples he used is the cost-benefit analysis in Ford Pinto case. Cost Benefits Increased Health Care costs Tax revenue from cigarette sales (due to lung cancer) Health care savings (from early deaths) Pension savings Savings in housing costs If we can not put a price tag on human life, can we put a price tag on 3 months or 6 months of human life?